Skip to content

On this page

Elzonris

tagraxofusp-erzs

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Elzonris

Proper name

tagraxofusp-erzs

Licence type

351(a)

BLA number

761116

Applicant

Stemline Therapeutics, Inc.

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
1,000MCG/1ML	Injection	Intravenous	Single-Dose Vial	Rx	December 21, 2018

Exclusivity

Source: Purple Book

Kind	Expires
Orphan exclusivity	December 21, 2025

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity